WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

  • WJAHR: OCTOBER ISSUE PUBLISHED

    OCTOBER 2026 Issue has been successfully launched on1 OCTOBER 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR October 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

THE INCIDENCE OF THALASSEMIA IN PREMARITAL TESTING IN MOSUL CITY: A RETROSPECTIVE CROSS-SECTIONAL STUDY

Dr. Nada Nazar Qasim Al Safar*, Dr. Anfal Mumtaz Ahmed Al Mukhtar, Dr. Ruba Mohammed Ibrahim

ABSTRACT

Background: Thalassemia is an inherited haemoglobin disorder that represents an important public health concern in Iraq. Premarital screening facilitates the identification of carriers, genetic counselling, and assessment of reproductive risks among prospective couples. Objectives: To assess the frequency of recorded thalassemia-related findings among individuals attending premarital screening centres in Mosul City, with consideration of laboratory parameters, ABO blood groups, Rhesus factor, and parental consanguinity. Methods: A retrospective cross-sectional study was designed to evaluate premarital screening records from Ibn Sina Teaching Hospital, Ibn Al-Atheer Teaching Hospital, and Mosul General Hospital over the period from 2 January 2021 to 31 May 2026. The variables of interest included sex, haemoglobin concentration, haemoglobin A? (HbA?), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), ABO blood group, Rhesus factor, parental consanguinity, and alpha- and beta-thalassemia status. Results: The available screening records for 2021–2025 included 213,510 individuals, among whom 6,352 were recorded as affected, representing 2.98% of the screened population. Males constituted 54.91% of affected cases, while females accounted for 45.09%. Beta-thalassemia represented 66.33%, alpha-thalassemia 10.20%, and other or undetermined findings 23.47%. The study demonstrated lower mean haemoglobin concentration among females than males (11.86 ± 1.34 versus 13.24 ± 1.47 g/dL). Mean HbA? was 4.73 ± 0.79% in females and 4.68 ± 0.83% in males, while mean MCV and MCH were slightly lower among females. Moreover, the study found that blood group O was the most frequent (43.51%), followed by A (24.78%), B (23.50%), and AB (8.21%). Rh-positive status accounted for 90.13% of the proposed distribution, while parental consanguinity was estimated at 25.77%. Conclusions: Premarital screening represents an important public health strategy for identifying individuals with thalassemia-related abnormalities and reducing the risk of severe inherited haemoglobin disorders in Mosul City. Strengthening standardized screening protocols, confirmatory laboratory testing, genetic counselling, and accurate electronic recordkeeping is recommended to improve early carrier identification and facilitate the detection of at-risk couples.

[Full Text Article] [Download Certificate]